Delivery Order SPE2DB22D1002-SPE2DB25FLFJ9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $3,358.40 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,725.99 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60gm), a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This non-set-aside, firm fixed price delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. The award represents a child contract action under AmerisourceBergen's broader relationship with the federal government as a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Opzelura 1.5% cream in 60-gram units, with a ceiling value of $3,841.18 and a period of performance through April 28, 2025. The contract is a firm-fixed-price delivery order, which is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
- The Defense Logistics Agency awarded a $23,120.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram quantities, with a completion date of July 31, 2025. This non-set-aside award was issued on July 30, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,460.52 for Opzelura 1.5% Cream (60 grams) with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $1 billion through December 2026. The contract carries no set-aside designation and will be performed at the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, valued at $4,813.05. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The order is scheduled for ultimate completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Opzelura 1.5% cream in 60-gram units. The contract has a firm fixed price of $4,315.84 and an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,521.55, is for the supply of Opzelura 1.5% cream in 60 gram quantities. It is a firm fixed-price contract with a performance period through July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
- The Defense Logistics Agency awarded a $3,055.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60gm) on August 7, 2025, with completion scheduled for August 8, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFJ9Delivery Order
This delivery order, awarded on July 28, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Opzelura 1.5% Cream in 60-gram units with a ceiling value of $1,310.45. The award represents a firm fixed-price delivery order under a non-competitive, non-set-aside procurement, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Opzelura delivery represents one of numerous pharmaceutical product procurements fulfilled under this expansive framework, which supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/28/25 |